Glycemic Variability of Combination Therapies in T2DM

Clinical trial NCT07442006 · RECRUITING

Trial details

NCT number: NCT07442006
Sponsor: JW Pharmaceutical
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus (T2DM)

Start date: 2025-10-29
Primary completion: 2027-03-31
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.